225 related articles for article (PubMed ID: 35879510)
1. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.
Beal EW; Owen M; McNamara M; McAlearney AS; Tsung A
J Gastrointest Cancer; 2023 Jun; 54(2):332-356. PubMed ID: 35879510
[TBL] [Abstract][Full Text] [Related]
2. Interventions to Improve Surveillance for Hepatocellular Carcinoma in High-Risk Patients: A Scoping Review.
Beal EW; McNamara M; Owen M; McAlearney AS; Tsung A
J Gastrointest Cancer; 2024 Mar; 55(1):1-14. PubMed ID: 37328730
[TBL] [Abstract][Full Text] [Related]
3. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.
Dalton-Fitzgerald E; Tiro J; Kandunoori P; Halm EA; Yopp A; Singal AG
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):791-8.e1. PubMed ID: 25019694
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
Kanwal F; Singal AG
Gastroenterology; 2019 Jul; 157(1):54-64. PubMed ID: 30986389
[TBL] [Abstract][Full Text] [Related]
6. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
[TBL] [Abstract][Full Text] [Related]
7. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology.
Huang DQ; Singal AG; Kanwal F; Lampertico P; Buti M; Sirlin CB; Nguyen MH; Loomba R
Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):797-809. PubMed ID: 37537332
[TBL] [Abstract][Full Text] [Related]
9. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
[TBL] [Abstract][Full Text] [Related]
10. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
[TBL] [Abstract][Full Text] [Related]
11. Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
Deng LX; Mehta N
Dig Dis Sci; 2020 Dec; 65(12):3456-3462. PubMed ID: 32860090
[TBL] [Abstract][Full Text] [Related]
12. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.
Simmons OL; Feng Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):766-773. PubMed ID: 30056183
[TBL] [Abstract][Full Text] [Related]
13. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
14. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
16. Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.
Izzo F; Piccirillo M; Albino V; Palaia R; Belli A; Granata V; Setola S; Fusco R; Petrillo A; Orlando R; Tosone G; Scordino F; Curley SA
HPB (Oxford); 2013 Dec; 15(12):985-90. PubMed ID: 23607636
[TBL] [Abstract][Full Text] [Related]
17. [Current Status and Future Directions of Hepatocellular Carcinoma Surveillance Test Based on Cost-effective Analysis].
An J
Korean J Gastroenterol; 2021 Nov; 78(5):255-260. PubMed ID: 34824183
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma surveillance: An evidence-based approach.
Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
[TBL] [Abstract][Full Text] [Related]
19. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.
Singal AG; Tiro JA; Murphy CC; Blackwell JM; Kramer JR; Khan A; Liu Y; Zhang S; Phillips JL; Hernaez R
Clin Gastroenterol Hepatol; 2021 May; 19(5):987-995.e1. PubMed ID: 32629122
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
